At the time of writing, AVITA Medical Inc [RCEL] stock is trading at $5.63, down -2.93%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RCEL shares have gain 32.47% over the last week, with a monthly amount glided 3.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AVITA Medical Inc [NASDAQ: RCEL] stock has seen the most recent analyst activity on August 08, 2025, when BTIG Research downgraded its rating to a Sell but kept the price target unchanged to $3 for it. Previously, D. Boral Capital started tracking the stock with Buy rating on December 24, 2024, and set its price target to $25. On April 11, 2024, downgrade downgraded it’s rating to Neutral. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $23 on June 27, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $27 as its price target on March 02, 2021. BofA Securities started tracking with a Buy rating for this stock on August 27, 2020, and assigned it a price target of $42. In a note dated April 21, 2020, Oppenheimer initiated an Outperform rating and provided a target price of $9 on this stock.
For the past year, the stock price of AVITA Medical Inc fluctuated between $3.60 and $14.16. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. AVITA Medical Inc [NASDAQ: RCEL] shares were valued at $5.63 at the most recent close of the market. An investor can expect a potential return of 104.26% based on the average RCEL price forecast.
Analyzing the RCEL fundamentals
According to AVITA Medical Inc [NASDAQ:RCEL], the company’s sales were 74.88M for trailing twelve months, which represents an 21.21% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.62%, Pretax Profit Margin comes in at -0.69%, and Net Profit Margin reading is -0.69%. To continue investigating profitability, this company’s Return on Assets is posted at -0.89, Equity is 279.91 and Total Capital is 10.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.51 points at the first support level, and at 5.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.80, and for the 2nd resistance point, it is at 5.97.
Ratios To Look Out For
It is important to note that AVITA Medical Inc [NASDAQ:RCEL] has a current ratio of 0.58. As well, the Quick Ratio is 0.46, while the Cash Ratio is 0.2. Considering the valuation of this stock, the price to sales ratio is 1.87.
Transactions by insiders
Recent insider trading involved O’Toole David D, CFO, that happened on Aug 12 ’25 when 2000.0 shares were purchased. Director, McNamara Robert completed a deal on Mar 06 ’25 to buy 11000.0 shares. Meanwhile, Director McNamara Robert bought 10000.0 shares on Feb 20 ’25.
